Develops evidence-driven fatty acid supplements and food fortifiers to replenish cellular micronutrients and counteract age-related metabolic decline.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Discover C15:0 operates a health and wellness biotechnology platform dedicated to advancing global health and healthy aging through the discovery and development of essential fatty acid therapeutics. Spun out of translation research involving marine mammal cohorts, the company researches and commercializes evidence-driven micronutrients and metabolites that replenish age-related deficiencies.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Seraphina Therapeutics Valuations & Financials
View real-time NPM data on Seraphina Therapeutics stock including daily Seraphina Therapeutics stock price estimates, valuation history, and historical share price information. Access Seraphina Therapeutics financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Seraphina Therapeutics pricing across six independent market signals. Looking for private company due diligence data sources on Seraphina Therapeutics? Get in touch to learn more.
Similar Companies
like Seraphina Therapeutics
Podium
Enterprise Software
Customer messaging platform enabling companies to connect at critical touch points.
Anthems
Media & Entertainment
Lets users highlight their music taste, join community topics and discover songs shared by other fans.
InsideTracker
Healthcare & Life Sciences
Provides personalized health insights and recommendations by analyzing blood, DNA, and fitness data to help users optimize wellness and performance.
Boost Biomes
Climate & Sustainability
Engineers microbial communities to boost crop health, yields and post-harvest longevity.
Volt SAS
Climate & Sustainability
Provides utility-scale solar energy solutions that integrate clean power delivery with community-focused environmental and equity initiatives.
Athos Therapeutics
Healthcare & Life Sciences
Develop therapies that leverage AI and omics data to target inflammatory and autoimmune diseases with precision small molecules.
BookNook
Consumer
Delivers live, research-based reading and math tutoring for K–8 students through an online platform in partnership with schools.
SweetLabs
Enterprise Software
Delivers app distribution that enables developers and device makers to recommend and monetize apps via dynamic, connected platforms.
Josh.ai
AI & Machine Learning
Develops AI-powered smart home systems for voice and app-based control of lighting, climate, security, and entertainment.
FAQ
We have answers
Seraphina Therapeutics stock does not trade on public stock exchanges. Seraphina Therapeutics stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Seraphina Therapeutics stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Seraphina Therapeutics Stock does not trade on public stock exchanges. In order to sell Seraphina Therapeutics shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Seraphina Therapeutics does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Seraphina Therapeutics share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Seraphina Therapeutics stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Seraphina Therapeutics stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Seraphina Therapeutics stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Seraphina Therapeutics is a private company and has not had an IPO. There is currently no Seraphina Therapeutics IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Seraphina Therapeutics IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
